NUR 372 EXAM 2 MEDICATIONS Flashcards

1
Q

CLASS: ALBUTEROL

A
  • beta2-adrenergic agonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

THERAPEUTIC USE: ALBUTEROL

A
  • long-term management of asthma
  • prevention of exercise-induced asthma
  • treatment of ongoing asthma exacerbations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SIDE/ADVERSE EFFECTS: ALBUTEROL

A
  • tachycardia
  • heart palpitations
  • angina
  • tremors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NURSING INTERVENTIONS: ALBUTEROL

A
  • monitor and report tachycardia, heart palpitations, and chest pain
  • monitor and report tremors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PATIENT INSTRUCTIONS: ALBUTEROL

A
  • report chest pain and palpitations
  • report increase in pulse rate
  • avoid caffeine
  • notify provider if tremors interfere with ADLs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MECHANISM OF ACTION: ALBUTEROL

A
  • acts by selectively activating the beta2-receptors in the bronchial smooth muscle, resulting in bronchodilation and decreased airway resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CLASS: FUROSEMIDE

A
  • loop diuretic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

THERAPEUTIC USE: FUROSEMIDE

A
  • treats pulmonary edema in heart failure
  • treats edema caused by renal, hepatic or cardiac failure not affected by other diuretics
  • treats hypertension not controlled by other diuretics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ADVERSE EFFECTS: FUROSEMIDE

A
  • hypotension
  • electrolyte imbalance (hyponatremia, hypochloremia, dehydration, hypokalemia)
  • ototoxicity
  • hyperglycemia
  • increased uric acid levels with gouty arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

NURSING INTERVENTIONS: FUROSEMIDE

A
  • monitor serum electrolyte levels; notify provider of abnormal levels
  • monitor for signs of electrolyte imbalance
  • if hypokalemia occurs, monitor for cardiac dysdysrhythmias
  • if hypokalemia is a risk, furosemide can be combined with a potassium-sparing diuretic
  • monitor blood glucose
  • ensure patient does not take other ototoxic drugs
  • monitor for hearing loss, tinnitus, vertigo
  • monitor uric acid levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PATIENT INSTRUCTIONS: FUROSEMIDE

A
  • eat foods rich in potassium
  • report signs of electrolyte imbalance: confusion, muscle twitching, weakness, nausea
  • teach patient to have BP monitored
  • report dizziness, syncope
  • report new onset of hearing loss, ringing in ears, or vertigo
  • carefully monitor blood glucose
  • patients who have history of gout need to report symptom onset to provider
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MECHANISM OF ACTION: FUROSEMIDE

A
  • inhibit reabsorption of Na+ and Cl- in ascending limb of the loop of Henle to prevent reabsorption of water
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CLASS: BISACODYL

A
  • stimulant laxatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

THERAPEUTIC USES: BISACODYL

A
  • constipation from opioid use or from slow intestinal transit
  • colon evacuation prior to elective procedures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ADVERSE EFFECTS: BISACODYL

A
  • diarrhea
  • abdominal cramps
  • burning sensation (suppositories)
  • prostates (prolonged use)
  • laxative abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NURSING INTERVENTIONS: BISACODYL

A
  • monitor for severe diarrhea and dehydration
  • tell patients to expect rectal/anal burning
  • monitor for rectal discomfort, bleeding, or discharge of mucus or pus
  • discourage long-term use
  • monitor I&O
  • monitor BM pattern
17
Q

PATIENT INSTRUCTIONS: BISACODYL

A
  • report severe diarrhea and stop taking drugs
  • drink fluids
  • expect burning sensation with suppository use
  • report rectal discomfort, bleeding, or discharge
  • do not use repeatedly or for extended periods
  • increase in fluid intake and add high-fiber foods slowly
18
Q

MECHANISM OF ACTION: BISACODYL

A
  • stimulation of intestinal peristalsis
19
Q

CLASS: COLACE

A
  • stool softener
20
Q

THERAPEUTIC USE: COLACE

A
  • constipation

- prevention of fecal impaction, straining during defecation, painful elimination of hard stools

21
Q

ADVERSE EFFECTS: COLACE

A
  • diarrhea

- mild abdominal cramps

22
Q

NURSING INTERVENTIONS: COLACE

A
  • monitor for severe diarrhea and dehydration
23
Q

PATIENT INSTRUCTIONS: COLACE

A
  • report severe diarrhea and stop taking drug
  • drink fluids
  • increase exercise, fluid intake, and consume high-fiber foods
24
Q

MECHANISM OF ACTION: COLACE

A
  • lower surface tension of the stool to allow penetration of water
25
CLASS: FLUTICASONE
- glucocorticoid
26
THERAPEUTIC USES: FLUTICASONE
- long-term prophylaxis
27
ADVERSE EFFECTS: FLUTICASONE
- URI - cough - sinusitis - sinus infection - throat irritation - oral thrush - headache
28
PATIENT TEACHING: FLUTICASONE
- decrease strength of immune system and mask signs of infection - administer on a fixed schedule - oral care after administration
29
MECHANISM OF ACTION: FLUTICASONE
- decrease inflammation and swelling of airways, suppress mucus production, promote responsiveness of beta2-receptors
30
CLASS: SPIRINOLACTONE
- potassium-sparing diuretics
31
THERAPEUTIC USE: SPIRINOLACTONE
- hypertension - edema caused by HF - cirrhosis of the liver - nephrotic syndrome - hypokalemia
32
ADVERSE EFFECTS: SPIRINOLACTONE
- hyperkalemia - menstrual irregularities - abnormal hair growth - deepening of voice in women - gyenocomastia in men
33
NURSING INTERVENTIONS: SPIRINOLACTONE
- monitor serum potassium levels - monitor for cardiac dysrhythmias if hyperkalemia occurs - may be combined with thiazide or loop diuretic to maintain normal potassium level - report endocrine effects
34
PATIENT INSTRUCTIONS: SPIRINOLACTONE
- report palpitations, irregular pulse, or signs of hyperkalemia - avoid potassium supplements or large amounts of foods high in potassium and salt substitutes - report endocrine symptoms
35
MECHANISM OF ACTION: SPIRINOLACTONE
- block the effect of aldosterone on renal tubules resulting in the loss of sodium and water and retaining potassium